Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
REGN
REGN
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
REGN News
Sanofi's COVID-19 Vaccine Shows Better Tolerability than Moderna's
18h ago
NASDAQ.COM
Teva's FDA Approval of Long-Acting Drug Could Be Major Catalyst
1d ago
NASDAQ.COM
Teva Pharmaceutical Shares Surge 130% with Optimistic Outlook
1d ago
Fool
AbbVie Ventures into Weight Loss Market with Promising Drug
5d ago
Fool
Regeneron and Telix Collaborate on Radiopharmaceuticals
6d ago
seekingalpha
Dupixent Approved by EU for Pediatric CSU Treatment
6d ago
NASDAQ.COM
Telix and Regeneron Collaborate on Next-Gen Radiopharmaceuticals
6d ago
Globenewswire
Regeneron and Telix Collaborate on Next-Gen Radiopharmaceuticals
6d ago
Newsfilter
European Commission Approves DPREMIUM
6d ago
Yahoo Finance
Dupixent Approved in EU for Children with CSU
6d ago
seekingalpha
Dupixent Approved by EU for Pediatric CSU Treatment
6d ago
NASDAQ.COM
Dupixent Approved in EU for Treating Children with CSU
6d ago
Newsfilter
Dupixent Approved in EU for Children with CSU
6d ago
Newsfilter
Sanofi and Regeneron's Dupixent Receives EU Approval as the First Targeted Treatment for Young Children with Chronic Spontaneous Urticaria
6d ago
moomoo
Telix and Regeneron Collaborate on Next-Gen Radiopharmaceuticals
6d ago
NASDAQ.COM
Telix and Regeneron Collaborate on Radiopharmaceutical Development
Apr 12 2026
Yahoo Finance
Show More News
